DE60317537T8 - Präoperative behandlung von brustkrebs - Google Patents

Präoperative behandlung von brustkrebs Download PDF

Info

Publication number
DE60317537T8
DE60317537T8 DE60317537T DE60317537T DE60317537T8 DE 60317537 T8 DE60317537 T8 DE 60317537T8 DE 60317537 T DE60317537 T DE 60317537T DE 60317537 T DE60317537 T DE 60317537T DE 60317537 T8 DE60317537 T8 DE 60317537T8
Authority
DE
Germany
Prior art keywords
breast cancer
preoperative treatment
treatment
preoperative
dppe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60317537T
Other languages
German (de)
English (en)
Other versions
DE60317537T2 (de
DE60317537D1 (de
Inventor
Lorne J. Winnipeg Brandes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Original Assignee
University of Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba filed Critical University of Manitoba
Application granted granted Critical
Publication of DE60317537D1 publication Critical patent/DE60317537D1/de
Publication of DE60317537T2 publication Critical patent/DE60317537T2/de
Publication of DE60317537T8 publication Critical patent/DE60317537T8/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60317537T 2002-09-03 2003-09-02 Präoperative behandlung von brustkrebs Active DE60317537T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40724202P 2002-09-03 2002-09-03
US407242P 2002-09-03
PCT/CA2003/001335 WO2004022163A1 (en) 2002-09-03 2003-09-02 Neoadjuvant treatment of breast cancer

Publications (3)

Publication Number Publication Date
DE60317537D1 DE60317537D1 (de) 2007-12-27
DE60317537T2 DE60317537T2 (de) 2008-10-23
DE60317537T8 true DE60317537T8 (de) 2009-02-05

Family

ID=31978443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317537T Active DE60317537T8 (de) 2002-09-03 2003-09-02 Präoperative behandlung von brustkrebs

Country Status (9)

Country Link
US (2) US20060160755A1 (https=)
EP (1) EP1545709B1 (https=)
JP (1) JP2006516532A (https=)
KR (1) KR20060039387A (https=)
AT (1) ATE378089T1 (https=)
AU (1) AU2003269621A1 (https=)
CA (1) CA2497246A1 (https=)
DE (1) DE60317537T8 (https=)
WO (1) WO2004022163A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798339A (en) * 1990-12-17 1998-08-25 University Of Manitoba Treatment method for cancer
US5618846A (en) * 1990-12-17 1997-04-08 University Of Manitoba Treatment method for cancer
US5616846A (en) * 1994-10-27 1997-04-01 Kwasnik; Joseph W. Method and apparatus for current regulation and temperature compensation
PL369792A1 (en) * 2001-11-01 2005-05-02 Ym Biosciences, Inc. Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
US20050119263A1 (en) * 2001-11-09 2005-06-02 Vincent Mark D. Treatment of breast cancer

Also Published As

Publication number Publication date
DE60317537T2 (de) 2008-10-23
CA2497246A1 (en) 2004-03-18
EP1545709B1 (en) 2007-11-14
EP1545709A1 (en) 2005-06-29
US20080318880A1 (en) 2008-12-25
KR20060039387A (ko) 2006-05-08
ATE378089T1 (de) 2007-11-15
WO2004022163A1 (en) 2004-03-18
JP2006516532A (ja) 2006-07-06
US20060160755A1 (en) 2006-07-20
DE60317537D1 (de) 2007-12-27
AU2003269621A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
UY27812A1 (es) Uso de docetasel-doxorubin-ciclofosfamida como apoyo de terapias
ATE341550T1 (de) Quinolinyl-pyrrolopyrazole
CY1111797T1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
NO20032027L (no) Effektive antitumorbehandlinger
PA8588601A1 (es) Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular
NO20022065D0 (no) Terapeutisk anvendelse
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
CY1109758T1 (el) Ηλεκτρομαγνητικη διεγερση ασθενων με οστεοπορωση
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
CY1115629T1 (el) Χρηση ενωσεων πεπτιδιου τρο και φαρμακευτικων συνθεσεων στην θεραπεια της αναιμιας
SE0300098D0 (sv) Use of cyclin D1 inhibitors
DE60323529D1 (de) Rutheniumkomplexe mit antikrebswirkung
ATE378089T1 (de) Präoperative behandlung von brustkrebs
AR034716A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
PL366066A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka sutka
GEP201606538B (en) Preoperative treatment of post operative pain
FR2825279B1 (fr) Medicament utile dans le traitement du cancer
JP2004521140A5 (https=)
NZ527655A (en) Combination of a taxane (docetaxel) and a cyclin-dependent kinase inhibitor (flavopiridol)
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
ATE385798T1 (de) Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
AR073585A1 (es) Una proteina rica en cisteina derivada de suero en pacientes que reciben quimioterapia o radioterapia para mejorar la supervivencia de dichos pacientes. uso. metodo
RU2007115500A (ru) Способ комбинированного лечения рака легкого iii стадии

Legal Events

Date Code Title Description
8364 No opposition during term of opposition